Access to critical medicines: When are compulsory licenses effective in price negotiations?

THE WORLD MEDICINES SITUATION 2011

Barbara Milani · 2011 · 431 citations

Public Affairs, Pharmaceutical Policy, Global Health +5

Economic Foundations of Intellectual Property Rights

Joseph E. Stiglitz · Duke Law Journal · 2008 · 207 citations · Full text

Social Sciences, Business Economics, Economics +10

Trade, TRIPS, and pharmaceuticals

Richard Smith, Carlos Correa, Cecilia Oh · The Lancet · 2009 · 175 citations

Law, Pharmaceutical Policy, International Economics +9

Trends in Compulsory Licensing of Pharmaceuticals Since the Doha Declaration: A Database Analysis

Reed F. Beall, Randall Kuhn · PLoS Medicine · 2012 · 166 citations · Full text

Pharmacy, Intellectual Property Law, Pharmaceutical Policy +15

The Doha Round's Public Health Legacy: Strategies for the Production and Diffusion of Patented Medicines under the Amended TRIPS Provisions -super-†

eYLS (Yale Law School) · 2007 · 150 citations · Full text

Law, Intellectual Property Law, Pharmaceutical Policy +16